Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pleural Effusion, Malignant 4 Breast Neoplasms 4 Immunoglobulin Light-chain Amyloidosis 3 Colorectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Mycosis Fungoides 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Non-Hodgkin 2 Exanthema 2 Amyloidosis 2 Waldenstrom Macroglobulinemia 1 Urologic Neoplasms 1 Tuberous Sclerosis 1 Triple Negative Breast Neoplasms 1 Tissue Adhesions 1 Skin Toxicity 1 Sezary Syndrome 1 Ras-wildtype Colorectal Cancer 1 Polyps 1 Polycystic Ovary Syndrome 1 Pain 1 Ovarian Neoplasms 1 Neurofibromatosis 2 1 Neoplasms, Second Primary 1 Neoplasms 1 Myoma 1 Menstruation Disturbances 1 Melanoma 1

Interventions

Fentanyl 23 Analgesia 22 Morphine 19 Acupuncture Therapy 18 Zoledronic Acid 15 Oxycodone 14 Acetaminophen 14 Ketamine 13 Radiotherapy 12 Therapeutics 11 Methadone 11 Lidocaine 11 nabiximols 10 Ibandronic Acid 10 Hydromorphone 10 Bupivacaine 10 Surveys and Questionnaires 8 Ropivacaine 8 Psychiatric Rehabilitation 7 Early Intervention, Educational 7 Saline Solution 6 Music Therapy 6 Cryotherapy 6 Cryosurgery 6 Yoga 5 Water 5 Tapentadol 5 Pregabalin 5 Methods 5 Massage 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Pain × Doxycycline × Clear all

NCT01847976 2019-09-06

OTT12-05

Ottawa Hospital Research Institute

Phase 2 Completed

Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡